Alzamend Neuro, INC. (ALZN) — DEFA14A Filings
All DEFA14A filings from Alzamend Neuro, INC.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
Alzamend Neuro Files Proxy Statement Amendment
— Mar 19, 2025 Risk: low
Alzamend Neuro, Inc. filed an amended proxy statement (DEFA14A) on March 19, 2025. This filing is an amendment to a previous filing and is considered definitive -
Alzamend Neuro Files Proxy Statement Amendment
— Mar 17, 2025 Risk: low
Alzamend Neuro, Inc. filed an amendment (Amendment No. 1) to its Definitive Proxy Statement on March 17, 2025. This filing concerns the solicitation of proxies -
Alzamend Neuro Files Proxy Statement Amendment
— Jun 11, 2024 Risk: low
Alzamend Neuro, Inc. filed an amendment (DEFA14A) on June 11, 2024, regarding its proxy statement. The filing indicates no fee was required for this submission,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX